Case Study: a biopharmaceutical company advances a virtual Phase IV ADHD trial with ObvioHealth

Global Biopharmaceutical Company - Customer Case Study

A global biopharmaceutical company faced the challenge of conducting a more inclusive Phase IV trial for its ADHD therapeutic. The study needed to enroll a real-world population of adults with co-morbid mood symptoms and concurrent medications, a broader scope than the narrow criteria of its earlier trials. To capture data in a real-world setting, the company needed to manage remote reporting from clinicians and patients, as well as integrate digital device readings for blood pressure and pulse.

The vendor, ObvioHealth, implemented a fully virtual solution for the trial. This solution included remote screening, telehealth visits, ePRO for patient-reported outcomes, and the shipping of sensors directly to patients to capture vital signs. The study, which is ongoing, leverages ObvioHealth's proprietary platform and mobile app to facilitate this decentralized approach, enabling safer and more efficient data collection from participants in their own homes.